Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀÎÁø¾¦ÀÇ ±¸°­¼¼±Õ¿¡ ´ëÇÑ Ç×±ÕÀÛ¿ë

Antibacterial Activity of Artemisa Capillaris THUNB on Oral Bacteria

´ëÇѱ¸°­³»°úÇÐȸÁö 2009³â 34±Ç 2È£ p.169 ~ 177
ä±Ôâ, ¾î±Ô½Ä, Àü¾çÇö, È«ÁøÇ¥,
¼Ò¼Ó »ó¼¼Á¤º¸
ä±Ôâ ( Chae Gyu-Chang ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
¾î±Ô½Ä ( Auh Q-Schick ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
Àü¾çÇö ( Chun Yang-Hyun ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
È«ÁøÇ¥ ( Hong Jung-Pyo ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç

Abstract

õ¿¬ ½Ä¹° ÃßÃâ¹°À» ±¸°­ Áúȯ¿¡ È°¿ëÇÏ´Â ¹æ¾ÈÀ» ¸ð»öÇϱâ À§ÇÏ¿©, º» ¿¬±¸´Â ÀÎÁø¾¦¿¡¼­ ÃßÃâÇÑ ¾¦ÃßÃâ¾×À» Ä¡ÀÇÇко߿¡ È°¿ëÇÏ°íÀÚ S. gordonii Challis, S. gordoii G9B, S. mutans GS5, S. sobriuns 6715, E. faecalis ATCC 4083, A. actinomycetem Y4, P. gingivalis A7A1-28, P. gingivalis W83, Pr. intermedia ATCC 25611, F. nucleatum KTCT 2488, C. albicans ATCC 18804¿¡ ´ëÇÑ Ç×±ÕÈ¿°ú¸¦ ¹Ì»ý¹°ÇÐÀûÀ¸·Î ½ÇÇèÇÏ¿©, »ý±Õ¼ö °Ë»ç¸¦ ÅëÇØ ´ÙÀ½°ú °°Àº °á°ú¸¦ ¾òÀ» ¼ö ÀÖ¾ú´Ù.
1. ÀÎÁø¾¦ÃßÃâ¾×¿¡ ÀÇÇÑ ÃÖ¼Ò¾ïÁ¦³óµµ(minimum inhibitory concentration; MIC)¿Í ÃÖ¼Ò»ì±Õ³óµµ(minimum bactericidal concentration; MBC)°¡ ¸ðµÎ ¾¦ÃßÃâ¾× ³óµµ 2.0%ÀÌÇÏ¿¡¼­ °üÂûµÈ ¼¼±ÕÀº Ä¡ÁÖÁúȯ ¿øÀαÕÀÎ P. gingivalis A7A1-28¿Í P. gingivalis W83, Pr. intermedia ATCC 25611·Î ³ªÅ¸³µ´Ù.
2. P. gingivalis A7A1-28ÀÇ MIC´Â ¾¦ÃßÃâ¾× ³óµµ 1.2%, MBC´Â 2.0%·Î °üÂûµÇ¾ú´Ù.
3. P. gingivalis W83ÀÇ MIC´Â ¾¦ÃßÃâ¾× ³óµµ 1.4%, MBC´Â 2.0%·Î °üÂûµÇ¾ú´Ù.
4. Pr. intermedia ATCC 25611ÀÇ MIC´Â ¾¦ÃßÃâ¾× ³óµµ 1.2%, MBC´Â 2.0%·Î °üÂûµÇ¾ú´Ù.
õ¿¬ ÀÚ¿¬¹°ÁúÀÎ ÀÎÁø¾¦ÀÌ ±¸°­ÁúȯÀ» ÀÏÀ¸Å°´Â ´ëÇ¥ÀûÀÎ ±ÕÁÖ¿¡ ´ëÇÑ È¿°ú¸¦ ¿¬±¸ÇÑ º» ½ÇÇèÀÇ °á°ú, ÀÎÁø¾¦Àº ±¸°­ ¼¼±Õ, ƯÈ÷ P. gingivalis A7A1-28¿Í P. gingivalis W83, Pr. intermedia ATCC 25611¿¡ ´ëÇÑ Ç×±ÕÈ¿°ú°¡ ÀÖÀ½ÀÌ Áõ¸íµÇ¾ú´Ù. µû¶ó¼­ ÀÌ Ãµ¿¬¹°ÁúÀÌ ºÎÀÛ¿ëÀÌ ¾ø´Â ÇÑ°è ³»¿¡¼­ »ç¿ëµÈ´Ù¸é, ±¸°­ÁúȯÀÚÀÇ ±¸°­ ȯ°æ °³¼±À» À§ÇÑ Ä¡¾à, ±¸°­¼¼Ã´Á¦ µîÀÇ ±¸°­¿ëÇ°µéÀ» ÅëÇØ ÀÓ»ó¿¡ Àû±ØÀûÀ¸·Î »ç¿ëµÉ ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢µÈ´Ù.

Recently it is very interesting that the plant extracts use to prevent or treat the oral diseases.
The present study was performed to observe the antibacterial effect on S. gordonii Challis, S. gordoii G9B, S. mutans GS5, S. sobriuns 6715, E. faecalis ATCC 4083, A. actinomycetem Y4, P. gingivalis A7A1-28, P. gingivalis W83, Pr. intermedia ATCC 25611, F. nucleatum KTCT 2488, C. albicans ATCC 18804 of Artemisa capillaris THUNB employing the viable cell counts.
The results were as follows:
1. Minimum inhibitory concentration(MIC) and Minimum bactericidal concentration(MBC) of extracts of Artemisa capillaris THUNB for P. gingivalis A7A1-28, P. gingivalis W83, and Pr. intermedia ATCC 25611, which are the pathologic bacteria of periodontal diseases, was observed under 2%.
2. MIC of extracts of Artemisa capillaris THUNB for P. gingivalis A7A1-28 was determined to be 1.2% and MBC was determined to be 2.0% respectively.
3. MIC of extracts of Artemisa capillaris THUNB for P. gingivalis W83 was determined to be 1.4% and MBC was determined to be 2.0% respectively.
4. MIC of extracts of Artemisa capillaris THUNB for Pr. intermedia ATCC 25611 was determined to be 1.2% and MBC was determined to be 2.0% respectively.
The overall results indicate that Artemisa capillaris THUNB used for this study has a strong antibacterial activity against P. gingivalis A7A1-28, P. gingivalis W83, and Pr. intermedia ATCC 25611, which are the periodontopathic bacteria. Therefore, the extracts of Artemisa capillaris THUNB can be used as a candidate for prevention and therapeutic agent against periodontal diseases.

Å°¿öµå

ÀÎÁø¾¦;Ç×±ÕÈ¿°ú;Ä¡ÁÖÁúȯ;±¸°­¹Ì»ý¹°
Artemisa capillaris THUNB;Antibacterial effect;Periodontal disease;Oral bacteria

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI